As of April 5, more than 3,798,746 doses of the COVID-19 vaccine have been given across the state, which is nearly 85% of the 4,477,920 doses that have been delivered to our providers and long-term care programs. Washington is currently averaging 59,592 vaccine doses given each day.
The Washington Department of Health’s three-week forecast from the federal government shows a substantial decrease in Johnson & Johnson vaccine starting next week. The forecast is an estimate that helps with planning at the state and local level. The numbers are subject to change as vaccine availability from the federal government may change. It is not uncommon for additional doses to be added later in the week before orders are placed.
- Week of April 11: 386,810 total doses (191,560 first doses, 195,250 second doses)
- This includes 225,810 doses of Pfizer, 148,100 doses of Moderna, and 12,900 doses of Johnson & Johnson
- Week of April 18: 355,980 total doses (182,960 first doses, 173,020 second doses)
- This includes 203,580 doses of Pfizer, 148,100 doses of Moderna, and 4,300 doses of Johnson & Johnson
- Week of April 25: 356,940 total doses (180,620 first doses, 176,320 second doses)
- The includes 201,240 doses of Pfizer, 151,400 doses of Moderna, and 4,300 doses of Johnson & Johnson
Last week nearly 15 million doses of Johnson & Johnson vaccine were ruined at a manufacturing plant in Baltimore. Despite the loss, our federal partners have told us this should not have a major impact on vaccine allocations. Johnson & Johnson said it is still on track to meet its target of producing 100 million doses of vaccine for the United States by the end of May.
On top of its weekly state allocations, there is a new federal allocation coming to Washington that goes directly to dialysis clinics. The partnership increases access to the COVID-19 vaccine for patients and healthcare personnel in outpatient dialysis clinics who have been disproportionately affected by COVID-19 and are at high risk of severe illness.